Julie Maréchal-Jamil
Past Vice-Chair IGBA Biosimilars Committee
Director Biosimilars Policy & Science, Medicines for Europe
Since October 2015, Julie has become the coordinator of the Biosimilar Medicines Group, a sector group of Medicines for Europe. Before that, Julie was part of Medicines for Europe’s regulatory and scientific affairs team for 8 years, with responsibilities in the areas of Quality, Compliance, Environment, Health & Safety as well as Bioequivalence. MSc in Pharmacology by background, she previously worked for the pharmaceutical industry. Her work consists in the coordination of Biosimilar policy related activities and external liaison with policy makers, EU institutions, Medicines Agencies, International organisations, industry and professional associations as well as a broad range of stakeholders. Julie has gained experience in technical areas such as pharmaceutical development, project management, EU regulatory affairs as well as on EU pharmaceutical and health policies.
